AptaBio Therapeutics Revenue

In the year 2025, AptaBio Therapeutics had annual revenue of 3.70B KRW with 10.02% growth. AptaBio Therapeutics had revenue of 1.00B in the quarter ending December 31, 2025, with 34.57% growth.

Revenue

3.70B

Revenue Growth

+10.02%

P/S Ratio

53.18

Revenue / Employee

n/a

Employees

n/a

Market Cap

196.65B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.70B	336.93M	10.02%
Dec 31, 2024	3.36B	3.04B	937.76%
Dec 31, 2023	323.87M	275.52M	569.80%
Dec 31, 2022	48.35M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition